Echo Street Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-862
| Closed | -$309K | – | 62 |
|
2023
Q3 | $309K | Buy |
+862
| New | +$309K | ﹤0.01% | 368 |
|
2023
Q2 | – | Sell |
-1,131
| Closed | -$542K | – | 465 |
|
2023
Q1 | $542K | Buy |
+1,131
| New | +$542K | ﹤0.01% | 246 |
|
2022
Q4 | – | Sell |
-1,024
| Closed | -$427K | – | 501 |
|
2022
Q3 | $427K | Sell |
1,024
-258
| -20% | -$108K | ﹤0.01% | 314 |
|
2022
Q2 | $635K | Sell |
1,282
-324
| -20% | -$160K | 0.01% | 255 |
|
2022
Q1 | $905K | Buy |
1,606
+730
| +83% | +$411K | 0.01% | 259 |
|
2021
Q4 | $662K | Sell |
876
-322
| -27% | -$243K | ﹤0.01% | 348 |
|
2021
Q3 | $894K | Buy |
1,198
+215
| +22% | +$160K | 0.01% | 271 |
|
2021
Q2 | $633K | Buy |
983
+496
| +102% | +$319K | ﹤0.01% | 296 |
|
2021
Q1 | $278K | Buy |
+487
| New | +$278K | ﹤0.01% | 435 |
|
2020
Q3 | – | Sell |
-2,792
| Closed | -$1.26M | – | 143 |
|
2020
Q2 | $1.26M | Buy |
+2,792
| New | +$1.26M | 0.01% | 232 |
|